Cargando…
Antithrombotic therapy in peripheral arterial disease
BACKGROUND: Patients with peripheral arterial disease (PAD) are at increased risk for major adverse cardiovascular events (MACE) such as cardiovascular death, myocardial infarction, and stroke as well as major adverse limb events (MALE) such as amputation and acute limb ischemia. Therefore, preventi...
Autores principales: | Espinola-Klein, Christine, Weißer, Gerhard, Schmitt, Volker, Schwaderlapp, Melanie, Munzel, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606411/ https://www.ncbi.nlm.nih.gov/pubmed/36312276 http://dx.doi.org/10.3389/fcvm.2022.927645 |
Ejemplares similares
-
Differential Inhibition of Platelet Reactivity by Dual Therapy With Aspirin and Low-Dose Rivaroxaban in Peripheral Arterial Disease: A Pilot Study
por: Jurk, Kerstin, et al.
Publicado: (2022) -
Influence of Peripheral Transluminal Angioplasty Alongside Exercise Training on Oxidative Stress and Inflammation in Patients with Peripheral Arterial Disease
por: Koppe-Schmeißer, Franziska, et al.
Publicado: (2021) -
Antithrombotic Treatment in Lower Extremity Peripheral Arterial Disease
por: Gottsäter, Anders
Publicado: (2021) -
Antithrombotic Therapy for Chronic Kidney Disease Patients With Concomitant Atrial Fibrillation and Coronary Artery Disease
por: Lee, Kuo-Hua, et al.
Publicado: (2021) -
Antithrombotic regimens in females with symptomatic lower extremity peripheral arterial disease: protocol for a systematic review and meta-analysis
por: Strauss, Shira A, et al.
Publicado: (2021)